Second Intermezzo "Complete Response" Threatens Transcept's Partnership Payments

If approval is not gained by Sept. 23, partner Purdue Pharma will not have to make a $30 million milestone payment.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet